Our cophenetic correlation coefficient calculations (CCC) are in support of EMMPRIN/CD147, CD99, Cathepsin D, Intβ1, ADAM9/-17, and Galectin-3 being suitable biomarkers for glioma cells and potentially, SLGCs. This evidence concerns the gene CD99 and central nervous system cancer.